Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...

In a report released today, David Windley from Jefferies maintained a Hold rating on Humana (HUM – Research Report), with a price target of $244.00. The company’s shares close ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers ...

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare ...

Insurance companies are cautiously optimistic about the Trump administration’s policies for their industry: insurers saw ...

Shares of Humana Inc. HUM rose 1.39% to $234.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to 6,045.26 and the ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...